World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02524652
Date of registration: 06/08/2015
Prospective Registration: Yes
Primary sponsor: Centre Hospitalier Universitaire Vaudois
Public title: Local Infiltration Analgesia vs Adductor Canal Block for Analgesia After Anterior Cruciate Ligament Reconstruction
Scientific title: Postoperative Analgesic Efficacy of Local Infiltration Analgesia Versus Adductor Canal Block After Anterior Cruciate Ligament Reconstruction: A Randomised Controlled Double-blinded Trial
Date of first enrolment: September 2015
Target sample size: 104
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02524652
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Outcomes Assessor).  
Phase:  Phase 4
Countries of recruitment
Switzerland
Contacts
Name:     Eric Albrecht, PD Dr
Address: 
Telephone:
Email:
Affiliation:  CHUV
Key inclusion & exclusion criteria

Inclusion Criteria:

- patients from 18 to 50 years old scheduled to undergo anterior cruciate ligament
reconstruction

Exclusion Criteria:

- peripheral neuropathy

- pre-existing femoral neuropathy

- diabetes mellitus

- alcoholism

- drug addiction

- cancer with chemotherapy

- chronic pain state



Age minimum: 18 Years
Age maximum: 50 Years
Gender: All
Health Condition(s) or Problem(s) studied
Regional Anesthesia Morbidity
Infiltration
Rupture of Anterior Cruciate Ligament
Intervention(s)
Drug: Ropivacaine 0.5% 20 mLs
Primary Outcome(s)
Total morphine consumption (mg) [Time Frame: 24 h postoperatively]
Secondary Outcome(s)
Anterior cruciate ligament -Return to Sport after Injury scale [Time Frame: 8 months postoperatively]
Quadriceps muscle strength (numeric scale, 1-5) [Time Frame: 72 h postoperatively]
International Knee Documentation Committee score [Time Frame: 4 months postoperatively]
Pain scores (numeric rating scale, 0-10) at rest and on movement [Time Frame: 60 h postoperatively]
Pain scores (numeric rating scale, 0-10) at rest and on movement [Time Frame: 72 h postoperatively]
Pruritus (yes/no) [Time Frame: 72 h postoperatively]
International Knee Documentation Committee score [Time Frame: 8 months postoperatively]
Pain scores (numeric rating scale, 0-10) at rest and on movement [Time Frame: 12 h postoperatively]
Active flexion [Time Frame: 48 h postoperatively]
Postoperative nausea and vomiting (yes/no) [Time Frame: 48 h postoperatively]
Active flexion [Time Frame: 72 h postoperatively]
Distance walked (meters) [Time Frame: 24 h postoperatively]
Distance walked (meters) [Time Frame: 48 h postoperatively]
Pain scores (numeric rating scale, 0-10) at rest and on movement [Time Frame: 2 h postoperatively]
Active flexion [Time Frame: 24 h postoperatively]
Anterior Cruciate Ligament - Return to Sport after Injury scale [Time Frame: 4 months postoperatively]
Pain scores (numeric rating scale, 0-10) at rest and on movement [Time Frame: 36 h postoperatively]
Postoperative nausea and vomiting (yes/no) [Time Frame: 72 h postoperatively]
Total morphine consumption (mg) [Time Frame: 2 h postoperatively]
Quadriceps muscle strength (numeric scale, 1-5) [Time Frame: 24 h postoperatively]
Distance walked (meters) [Time Frame: 72 h postoperatively]
Pruritus (yes/no) [Time Frame: 24 h postoperatively]
Total morphine consumption (mg) [Time Frame: 72 h postoperatively]
Pain scores (numeric rating scale, 0-10) at rest and on movement [Time Frame: 24 h postoperatively]
Quadriceps muscle strength (numeric scale, 1-5) [Time Frame: 48 h postoperatively]
Pain scores (numeric rating scale, 0-10) at rest and on movement [Time Frame: 48 h postoperatively]
Postoperative nausea and vomiting (yes/no) [Time Frame: 24 h postoperatively]
Pruritus (yes/no) [Time Frame: 48 h postoperatively]
Total morphine consumption (mg) [Time Frame: 48 h postoperatively]
Secondary ID(s)
CER 193-15
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history